Found: 30
Select item for more details and to access through your institution.
Cellular metabolism: A key player in cancer ferroptosis.
- Published in:
- Cancer Communications, 2024, v. 44, n. 2, p. 185, doi. 10.1002/cac2.12519
- By:
- Publication type:
- Article
Endoplasmic reticulum stress—a key guardian in cancer.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02110-3
- By:
- Publication type:
- Article
Ferritinophagy: research advance and clinical significance in cancers.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01753-y
- By:
- Publication type:
- Article
PARP inhibitor resistance: the underlying mechanisms and clinical implications.
- Published in:
- Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01227-0
- By:
- Publication type:
- Article
USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 1, p. 97, doi. 10.4103/jcrt.jcrt_517_22
- By:
- Publication type:
- Article
USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 1, p. 97, doi. 10.4103/jcrt.jcrt_517_22
- By:
- Publication type:
- Article
Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis.
- Published in:
- Cell Proliferation, 2021, v. 54, n. 5, p. 1, doi. 10.1111/cpr.13029
- By:
- Publication type:
- Article
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-023-03186-0
- By:
- Publication type:
- Article
Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1222209
- By:
- Publication type:
- Article
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02634-z
- By:
- Publication type:
- Article
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02634-z
- By:
- Publication type:
- Article
TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02252-1
- By:
- Publication type:
- Article
Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy.
- Published in:
- Immunology, 2024, v. 173, n. 1, p. 14, doi. 10.1111/imm.13793
- By:
- Publication type:
- Article
Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05583-z
- By:
- Publication type:
- Article
The cancer metabolic reprogramming and immune response.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01316-8
- By:
- Publication type:
- Article
Combined clinical and genetic testing algorithm for cervical cancer diagnosis.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1100134
- By:
- Publication type:
- Article
Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.999654
- By:
- Publication type:
- Article
Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination.
- Published in:
- International Journal of Biological Sciences, 2024, v. 20, n. 4, p. 1125, doi. 10.7150/ijbs.91206
- By:
- Publication type:
- Article
Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials.
- Published in:
- International Journal of Biological Sciences, 2022, v. 18, n. 13, p. 5103, doi. 10.7150/ijbs.75410
- By:
- Publication type:
- Article
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential.
- Published in:
- Experimental & Molecular Medicine EMM, 2023, v. 55, n. 7, p. 1357, doi. 10.1038/s12276-023-01020-1
- By:
- Publication type:
- Article
The function of prohibitins in mitochondria and the clinical potentials.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02765-x
- By:
- Publication type:
- Article
Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02052-5
- By:
- Publication type:
- Article
Development of a novel transcription factors-related prognostic signature for serous ovarian cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86294-z
- By:
- Publication type:
- Article
SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway.
- Published in:
- Medical Oncology, 2023, v. 40, n. 2, p. 1, doi. 10.1007/s12032-022-01944-0
- By:
- Publication type:
- Article
CSF3 Is a Potential Drug Target for the Treatment of COVID-19.
- Published in:
- Frontiers in Physiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphys.2020.605792
- By:
- Publication type:
- Article
Radiomic Score as a Potential Imaging Biomarker for Predicting Survival in Patients With Cervical Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.706043
- By:
- Publication type:
- Article
TRPM7 promotes the epithelial–mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1061-y
- By:
- Publication type:
- Article
LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1‐p53/c‐Myc axis.
- Published in:
- Cancer Science, 2023, v. 114, n. 3, p. 870, doi. 10.1111/cas.15662
- By:
- Publication type:
- Article
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9.
- Published in:
- Cancer Science, 2023, v. 114, n. 3, p. 822, doi. 10.1111/cas.15652
- By:
- Publication type:
- Article